Australia’s highest court has ruled a gene mutation linked to cancer cannot be patented, ending a long battle over whether companies can own the rights to genetic material.
- Adjunct Professor, Murdoch University
The High Court challenge is the last resort for Ms D'Arcy’s test case against companies patenting human genes and has implications for patients, clinicians and researchers.
Ten years on from the Australia-US Free Trade Agreement, Australia is entering another round of negotiations towards the new and controversial Trans-Pacific Partnership. In this Free Trade Scorecard series…
A Federal Court decision to allow gene patents could open the way for existing patents to be enforced more strongly in Australia, according to an expert in intellectual property. Biotechnology companies…
Private firms are allowed to hold a patent over cancer-causing gene mutations, according to an historic ruling in the Federal Court today that has wide-ranging implications for researchers and cancer patients…
Michael Gilbert’s article starts with a title that poses a question - Will patenting crops help feed the hungry? Fair enough, except he then proceeds to provide an answer, which as the posted comments…
The US Court of Appeals for the Federal Circuit has found Myriad Genetics is entitled to patents on two sets human genetic mutations used to predict if women have an increased risk of breast and ovarian…
Read the argument against the proposed legislation Patents are only to be for granted inventions - that’s the intent of the Patents Act 1990, it has been the law for nearly 400 years, and it’s also what…
Contact Luigi for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Article Feed
- Joined
